Filter by: patients
Home > Community Treatment Reports and Side Effects > Lumigan Treatment Report
What is Lumigan?

Lumigan® is a brand name for the ophthalmic agent bimatoprost. It is used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Glaucoma 4 1 Efficacy_moderate
Intraocular pressure 2 0
Prevention for Glucoma as not easily detected with nerve damage to eyes and is in family history 1 0

See all 6 patients currently taking Lumigan

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  daily 0.03% daily 0.03 g daily
  1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4  

Reported Stop Reasons

Why Patients Stopped Taking Lumigan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Not indicated 1   Not indicated: 100%

See all 1 patient who’ve stopped taking Lumigan

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Lumigan

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Lumigan

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Lumigan

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Lumigan

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.